Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Sequencing » Vision Medicals Gets CE Mark for SARS-CoV-2 Clinical Sequencing Test

Vision Medicals Gets CE Mark for SARS-CoV-2 Clinical Sequencing Test

Mar 19, 2020
|
staff reporter

NEW YORK – Vision Medicals has received the CE-IVD mark for its SARS-CoV-2 Clinical Sequencing assay, which uses next-generation sequencing.

The test is built on a proprietary metagenomic sequencing assay that runs on an Illumina NextSeq sequencer. Each kit contains 36 tests and is able to detect SARS-CoV-2 at a sensitivity of 500 copies per milliliter. With the CE mark in hand, Vision Medicals plans to focus on the European market.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Areas of Limited Testing

The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations.

Clouded 'Crystal Ball'

According to NBC News, new SARS-CoV-2 variants are making it harder for researchers to model the course of the pandemic.

Million a Day

The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.

Science Papers Trace Drivers of Metastasis; Genetic Analysis of Stone, Bronze Age Eastern Europeans

In Science this week: single-cell lineage tracing technique applied to study lung cancer metastasis, and more.

Jan
26
Featured Webinar

Panel Discussion: Genotyping by Sequencing for Novel SNP Discovery with Less Common Genomes

Sponsored by
LGC, Biosearch Technologies

Reduced representation next-generation sequencing (NGS) methods are driving understanding of both physical and structural variation in all species.

Jan
28
Featured Webinar

Implementation of a Customized Myeloid NGS-based Solution in an Academic Clinical Laboratory

Sponsored by
Sophia Genetics

This webinar discusses how the University of Michigan has implemented a new next-generation sequencing (NGS) capture-based solution to assess myeloid malignancies while minimizing required laboratory resources. 

Feb
11
Featured Webinar

Virtual Molecular Tumor Board Series: HRD and DNA Damage Repair

Sponsored by
Foundation Medicine

In this session, the first in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified biomarkers related to homologous recombination deficiency and DNA damage repair.

Feb
17
Featured Webinar

Single-Cell Multiomics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

Sponsored by
BioLegend

Host immune responses play a central role in controlling SARS-CoV-2 infection, but they remain incompletely characterized and understood.

What's Popular?

In Sequencing

  1. Illumina Wins UK Patent Infringement Suit Against BGI, Affiliates

  2. Ancestry Shutters Health Offering, Raising Questions About Future of Consumer Genomics

    Premium

  3. Lung Cancer Metastasis Study Relies on CRISPR-Based Method to Track Single-Cell Lineages

  4. Breast Cancer Risk Gene Associations Refined in Large-Scale Studies

  5. Quest Diagnostics Wins CDC Contract to Sequence SARS-CoV-2 Samples

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.